Introduction
Trichomonas vaginalis is a protozoan which causes a non-self-limiting sexually transmitted disease that affects mostly women. The absence of any evidence indicating host immunity of this agent, even after repeated infections, is intriguing in the light of the presence of antibodies reactive with trichomonad immunogens in vaginal washes and sera of patients with trichomoniasis. 15 More recently, the cysteine proteinases of T vaginalis have received attention`for their possible role in participating in a variety of important virulence properties, such as cytadherence,6 host cytopathogenicity,6 [11] [12] [13] and nutrient acquisition." 4 The complexity of the total repertoire of cysteine proteinases was also demonstrated,9 as evidenced by the total number and differential expression of proteinases during in vivo and invitro growth of isolates. 9 Because Proteinases were detected by one dimensional electrophoresis using 7.5% acrylamide copolymerised with gelatin as substrate, which was performed as recently described.9 Attempts to analyse proteinases by two-dimensional electrophoresis9 as accomplished recently were unsuccessful, presumably because of the small amounts of proteinases being precipitated by the patient serum antibody.
Results
We tested for the presence of antibody to proteinases in the sera of patients. The figure shows the results of typical immunoprecipitation experiments. Onedimensional electrophoretic analysis for proteinases using gelatin as substrate revealed that all sera had IgG to proteinase, as evidenced by the patterns of proteinase reactivity. Only quantitative differences, based on the intensities of the proteinase bands, were observed in the sera of 50 patients with trichomoniasis which were tested. Control sera from women without any history of trichomoniasis`7 did not possess any IgG that precipitated any proteinases. Lastly, no differences were seen when S aureus was pretreated with either anti-human IgG or antihuman Ig, indicating that IgG was the predominant immunoglobulin in serum toward proteinases.
We also tested four patients from whom sera was obtained after one week following treatment with metronidazole. At this time the patient tested 
